相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of direct pathway striatal projection neurons by muscarinic M4-type receptors
Teresa Hernandez-Flores et al.
NEUROPHARMACOLOGY (2015)
M4 mAChR-Mediated Modulation of Glutamatergic Transmission at Corticostriatal Synapses
Tristano Pancani et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
Michael Bubser et al.
ACS CHEMICAL NEUROSCIENCE (2014)
M5 Receptor Activation Produces Opposing Physiological Outcomes in Dopamine Neurons Depending on the Receptor's Location
Daniel J. Foster et al.
JOURNAL OF NEUROSCIENCE (2014)
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study
Jane S. Paulsen et al.
LANCET NEUROLOGY (2014)
Clinical Trials in Huntington's Disease: Interventions in Early Clinical Development and Newer Methodological Approaches
Cristina Sampaio et al.
MOVEMENT DISORDERS (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
Anna Chiarlone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2013)
Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models
Sonia Marco et al.
NATURE MEDICINE (2013)
Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior
Susanne E. Ahmari et al.
SCIENCE (2013)
Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL/6J) Huntington's disease transgenic mice
Simon Brooks et al.
BRAIN RESEARCH BULLETIN (2012)
Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice
Zubeyde Bayram-Weston et al.
BRAIN RESEARCH BULLETIN (2012)
Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: An examination of the role of altered inhibitory and excitatory mechanisms
Andrew M. Farrar et al.
EXPERIMENTAL NEUROLOGY (2011)
Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease
Veronique M. Andre et al.
JOURNAL OF NEUROSCIENCE (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function
Shengli Zhao et al.
NATURE METHODS (2011)
In vivo dopamine efflux is decreased in striatum of both fragment (R6/2) and full-length (YAC128) transgenic mouse models of Huntington's disease
Joshua W. Callahan et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum
Andrea N. Ortiz et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
Austen J. Milnerwood et al.
NEURON (2010)
Earliest functional declines in Huntington disease
Leigh J. Beglinger et al.
PSYCHIATRY RESEARCH (2010)
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease
Rona K. Graham et al.
JOURNAL OF NEUROSCIENCE (2009)
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
Prasad R. Joshi et al.
JOURNAL OF NEUROSCIENCE (2009)
Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration
Michael J. Higley et al.
NATURE NEUROSCIENCE (2009)
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
J. S. Paulsen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated
Jennifer E. Ayala et al.
NEUROPHARMACOLOGY (2008)
Re-emergence of striatal cholinergic interneurons in movement disorders
Antonio Pisani et al.
TRENDS IN NEUROSCIENCES (2007)
Dopamine-depen dent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease
V. W. S. Kung et al.
NEUROSCIENCE (2007)
Dopamine-mediated regulation of corticostriatal synaptic plasticity
Paolo Calabresi et al.
TRENDS IN NEUROSCIENCES (2007)
Cholinergic interneurons control the excitatory input to the striatum
Pavel Pakhotin et al.
JOURNAL OF NEUROSCIENCE (2007)
Cholinergic neuronal defect without cell loss in Huntington's disease
Ruben Smith et al.
HUMAN MOLECULAR GENETICS (2006)
Altered cortical glutamate receptor function in the r6/2 model of Huntington's disease
VM André et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
M Day et al.
NATURE NEUROSCIENCE (2006)
Cleavage pattern and emerging asymmetry of the mouse embryo
MZ Zernicka-Goetz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease
AJ Starling et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study
CM Kipps et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROSCIENCE (2005)
Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements
NA DiProspero et al.
JOURNAL OF NEUROCYTOLOGY (2004)
High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity
KA Mark et al.
JOURNAL OF NEUROSCIENCE (2004)
M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission:: relevance to the pathophysiology and treatment of related central nervous system pathologies
ET Tzavara et al.
FASEB JOURNAL (2004)
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism
B Picconi et al.
BRAIN (2004)
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats
LB Menalled et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum
JM Vetter et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Shifts in striatal responsivity evoked by chronic stimulation of dopamine and glutamate systems
JJ Canales et al.
BRAIN (2002)
PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains
J Modregger et al.
HUMAN MOLECULAR GENETICS (2002)
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease
MA Hickey et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Subtle changes among presymptomatic carriers of the Huntington's disease gene
SC Kirkwood et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Functional anatomy of movement disorders
AR Crossman
JOURNAL OF ANATOMY (2000)
分享论文
